Zeda acquires The Orthopedic Implant Company

Zeda announced today that it agreed to acquire The Orthopaedic Implant Company (OIC) for an undisclosed amount.

San Francisco-based Zeda says the acquisition marks a “significant leap forward” in strengthening its commitment to “revolutionizing manufacturing and distribution of medical devices globally.”

OIC delivers high-quality, cost-effective orthopedic devices, Zeda said in a news release. The company believes the acquisitions enables it to produce OIC’s implant designs, fortifying and accelerating its mission to provide accessible, high-value trauma implants to patients.

Itai Nemovicher, OIC co-founder and CEO, said Zeda shares the company’s values in advancing access to critical orthopedic care. Nemovicher said that, under Zeda, OIC could “reach new heights” in providing orthopedic solutions in the U.S. and abroad.

Under the terms of the acquisition, OIC will operate worldwide as a Zeda Health …

Read more
  • 0

FDA clears dorsal spanning plate from The Orthopaedic Implant Company

[Image from OIC]The Orthopaedic Implant Company (OIC) announced today that the FDA cleared its dorsal spanning plate.

Reno, Nevada-based OIC will add the plate to its trauma implant portfolio to expand the potential clinical impact of its DRPx wrist fracture plating system.

According to a news release, the newly cleared product — which has now been commercially launched in the U.S. — represents the first and only high-value dorsal spanning plate on the market.

DRPx, which was launched in August 2021, supports a wide array of surgeons’ technique preferences while increasing cost-saving opportunities and improving the financial viability of ambulatory surgery centers (ASCs), hospitals and their patients, OIC said.

“If we want value-based care to work then implant companies have to play their part,” OIC President and CEO Itai Nemovicher said in the release. “The reality right now is that ASCs are only being reimbursed at 53% the …

Read more
  • 0